Flemming Pociot

Researcher Next ID · RN-038975

Researcher · Biochemistry, Genetics and Molecular Biology

University of Copenhagen

Copenhagen, Denmark

Accepting doctoral researchersFunding unknown

Works count: 440
Citation count: 22,513
H-index: 71
i10-index: 274

Research interests

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Medicine

Diabetes and associated disorders

Pancreatic function and diabetes

Diabetes Management and Research

Immune Cell Function and Interaction

MicroRNA in disease regulation

Publications

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes
Nature Genetics · 2021 · 10.1038/s41588-021-00880-5
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes
Nature Genetics · 2021 · 10.1038/s41588-021-00880-5
Genetic risk factors for type 1 diabetes
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30582-7
Transcriptomic landscape of lncRNAs in inflammatory bowel disease
Genome Medicine · 2015 · 10.1186/s13073-015-0162-2
Transcriptomic landscape of lncRNAs in inflammatory bowel disease
Genome Medicine · 2015 · 10.1186/s13073-015-0162-2
Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression
Experimental Diabetes Research · 2012 · 10.1155/2012/896362
TiSH — a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC
Journal of Proteomics · 2012 · 10.1016/j.jprot.2012.08.007
TiSH — a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC
Journal of Proteomics · 2012 · 10.1016/j.jprot.2012.08.007
Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression
Experimental Diabetes Research · 2012 · 10.1155/2012/896362
Genetics of Type 1 Diabetes: What's Next?
Diabetes · 2010 · 10.2337/db10-0076
Genetics of Type 1 Diabetes: What's Next?
Diabetes · 2010 · 10.2337/db10-0076
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
Nature Genetics · 2009 · https://doi.org/10.1038/ng.381
Relative predispositional effects of HLA class II DRB1‐DQB1 haplotypes and genotypes on type 1 diabetes: a meta‐analysis
Tissue Antigens · 2007 · https://doi.org/10.1111/j.1399-0039.2007.00867.x
A human phenome-interactome network of protein complexes implicated in genetic disorders
Nature Biotechnology · 2007 · https://doi.org/10.1038/nbt1295
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene
The American Journal of Human Genetics · 2005 · 10.1086/429391
Type 1 Diabetes
Diabetes · 2005 · 10.2337/diabetes.54.10.2995
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene
The American Journal of Human Genetics · 2005 · 10.1086/429391
Type 1 Diabetes
Diabetes · 2005 · 10.2337/diabetes.54.10.2995
Cytokine gene polymorphism in human disease: on-line databases, Supplement 2
Genes and Immunity · 2002 · 10.1038/sj.gene.6363881
Genetics of type 1 diabetes mellitus
Genes and Immunity · 2002 · 10.1038/sj.gene.6363875
Cytokine gene polymorphism in human disease: on-line databases, Supplement 2
Genes and Immunity · 2002 · 10.1038/sj.gene.6363881
Genetics of type 1 diabetes mellitus
Genes and Immunity · 2002 · 10.1038/sj.gene.6363875
Cytokine gene polymorphism in human disease: on-line databases, Supplement 1
Genes and Immunity · 2001 · 10.1038/sj.gene.6363733
Cytokine gene polymorphism in human disease: on-line databases, Supplement 1
Genes and Immunity · 2001 · 10.1038/sj.gene.6363733
CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?
Genes and Immunity · 2000 · 10.1038/sj.gene.6363655
CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?
Genes and Immunity · 2000 · 10.1038/sj.gene.6363655
The Predisposition to Type 1 Diabetes Linked to the Human Leukocyte Antigen Complex Includes at Least One Non–Class II Gene
The American Journal of Human Genetics · 1999 · 10.1086/302283
The Predisposition to Type 1 Diabetes Linked to the Human Leukocyte Antigen Complex Includes at Least One Non–Class II Gene
The American Journal of Human Genetics · 1999 · 10.1086/302283
Cytokine gene polymorphism in human disease: on-line databases
Genes and Immunity · 1999 · https://doi.org/10.1038/sj.gene.6363645
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele
Nature Genetics · 1997 · 10.1038/ng1197-350
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele
Nature Genetics · 1997 · 10.1038/ng1197-350
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31–q33
Nature Genetics · 1995 · 10.1038/ng0195-80
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31–q33
Nature Genetics · 1995 · 10.1038/ng0195-80
Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
Nature Genetics · 1995 · https://doi.org/10.1038/ng0395-284
On the pathogenesis of IDDM
Diabetologia · 1994 · 10.1007/bf00400830
On the pathogenesis of IDDM
Diabetologia · 1994 · 10.1007/bf00400830
Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus
European Journal of Immunology · 1993 · 10.1002/eji.1830230135
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
The Journal of Experimental Medicine · 1993 · 10.1084/jem.177.2.557
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
The Journal of Experimental Medicine · 1993 · 10.1084/jem.177.2.557
Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus
European Journal of Immunology · 1993 · 10.1002/eji.1830230135
A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro
European Journal of Clinical Investigation · 1992 · https://doi.org/10.1111/j.1365-2362.1992.tb01480.x
Cytokines and Free Radicals as Effector Molecules in the Destruction of Pancreatic Beta Cells
Current topics in microbiology and immunology · 1990 · 10.1007/978-3-642-75741-9_9
Cytokines and Free Radicals as Effector Molecules in the Destruction of Pancreatic Beta Cells
Current topics in microbiology and immunology · 1990 · 10.1007/978-3-642-75741-9_9

Current projects

No projects listed.